Recombine Obtains $8,438,335 New Round

  • Feed Type
  • Date
    7/8/2016
  • Company Name
    Recombine
  • Mailing Address
    1140 Broadway New York, NY 10001 USA
  • Company Description
    Recombine provides comprehensive and cost-effective clinical genetic testing. Recombine’s genetic test is designed to deliver clear and actionable genetic information and is based on input from leading healthcare providers.
  • Website
    http://www.recombine.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $8,438,335
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 3 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy